HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Kadomatsu Selected Research

Ligands

12/2021Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase.
7/2015CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
7/2009The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Kadomatsu Research Topics

Disease

40Neoplasms (Cancer)
04/2024 - 06/2002
17Inflammation (Inflammations)
11/2022 - 11/2004
14Neuroblastoma
10/2023 - 10/2008
9Spinal Cord Injuries (Spinal Cord Injury)
01/2021 - 04/2010
8Wounds and Injuries (Trauma)
05/2021 - 05/2003
7Carcinogenesis
04/2024 - 06/2005
7Kidney Diseases (Kidney Disease)
03/2024 - 06/2011
7Fibrosis (Cirrhosis)
08/2018 - 05/2003
6Ischemia
07/2015 - 04/2005
6Carcinoma (Carcinomatosis)
10/2008 - 06/2002
5Diabetic Nephropathies (Diabetic Nephropathy)
11/2023 - 01/2006
5Hyperplasia
10/2023 - 09/2006
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2017 - 11/2015
4Chronic Renal Insufficiency
11/2023 - 04/2010
4Multiple Sclerosis
01/2021 - 03/2012
4Acute Kidney Injury (Acute Renal Failure)
08/2018 - 10/2014
4Hypertension (High Blood Pressure)
08/2015 - 06/2009
4Prostatic Neoplasms (Prostate Cancer)
04/2015 - 05/2004
4Reperfusion Injury
02/2014 - 01/2002
3Alzheimer Disease (Alzheimer's Disease)
12/2023 - 02/2004
3Proteinuria
11/2023 - 08/2015
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 05/2014
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 01/2013
3Arthritis (Polyarthritis)
01/2017 - 10/2010
3Neointima
02/2014 - 05/2005
3Brain Injuries (Brain Injury)
03/2009 - 08/2006
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 05/2015
2Dermatitis
12/2021 - 12/2013
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2021 - 01/2021
2Stomach Neoplasms (Stomach Cancer)
07/2020 - 10/2007
2Hypoxia (Hypoxemia)
01/2020 - 01/2018
2Atherosclerosis
12/2017 - 06/2008
2Neuroinflammatory Diseases
08/2017 - 01/2016
2Lupus Nephritis
04/2017 - 05/2015
2Heart Failure
05/2016 - 01/2016
2Renal Insufficiency (Renal Failure)
05/2016 - 04/2005
2Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 03/2011
2Pathologic Constriction (Stenosis)
02/2014 - 06/2008
2Glomerulonephritis
02/2013 - 06/2011
2Contact Dermatitis (Eczema, Contact)
02/2012 - 02/2008
2Infarction (Infarctions)
01/2011 - 10/2006
2Myocardial Infarction
04/2010 - 02/2009
2Gliosis
11/2006 - 08/2006

Drug/Important Bio-Agent (IBA)

51MidkineIBA
04/2024 - 01/2002
27Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2021 - 06/2002
17Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2005
14Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
11/2023 - 05/2003
14Heparin (Liquaemin)FDA LinkGeneric
08/2021 - 06/2002
11Keratan SulfateIBA
01/2017 - 08/2006
10Small Interfering RNA (siRNA)IBA
04/2015 - 05/2004
6EnzymesIBA
01/2021 - 03/2003
6atelocollagenIBA
04/2015 - 06/2002
5Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2021 - 03/2009
5LipopolysaccharidesIBA
08/2017 - 04/2002
5Matrix Metalloproteinases (MMPs)IBA
04/2016 - 05/2003
4Therapeutic UsesIBA
09/2017 - 02/2012
4AcetylglucosamineIBA
12/2015 - 08/2006
4Hyaluronic Acid (Hyaluronan)IBA
07/2015 - 01/2011
3Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2008
3LigandsIBA
12/2021 - 07/2009
3ErbB Receptors (EGF Receptor)IBA
02/2021 - 05/2016
3NF-kappa B (NF-kB)IBA
01/2019 - 11/2006
3Polysaccharides (Glycans)IBA
01/2017 - 01/2014
3Messenger RNA (mRNA)IBA
01/2016 - 11/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 05/2004
3Cisplatin (Platino)FDA LinkGeneric
12/2009 - 11/2004
3Antisense OligonucleotidesIBA
06/2008 - 02/2004
2Glycoproteins (Glycoprotein)IBA
12/2023 - 04/2016
2GlycosyltransferasesIBA
12/2023 - 01/2016
2MicroRNAs (MicroRNA)IBA
11/2022 - 01/2019
2Imiquimod (Aldara)FDA LinkGeneric
12/2021 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 11/2006
2Interleukin-18 (Interleukin 18)IBA
01/2019 - 08/2017
2FructoseIBA
01/2019 - 01/2018
2Metalloproteases (Metalloproteinases)IBA
01/2019 - 07/2015
2Chondroitin Sulfate ProteoglycansIBA
12/2017 - 08/2013
2Bleomycin (Blenoxane)FDA LinkGeneric
08/2017 - 05/2003
2Transforming Growth Factors (Transforming Growth Factor)IBA
08/2017 - 07/2015
2CollagenIBA
08/2017 - 04/2015
23,3'-iminodipropionitrileIBA
08/2017 - 01/2016
2E-SelectinIBA
07/2015 - 07/2009
2Chondroitin ABC LyaseIBA
04/2015 - 03/2012
2Nucleotide AptamersIBA
02/2013 - 03/2012
2Tumor Biomarkers (Tumor Markers)IBA
07/2012 - 03/2003
2Proteoglycans (Proteoglycan)IBA
03/2012 - 11/2011
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2012 - 02/2008
2Collagen Type II (Type II Collagen)IBA
06/2011 - 10/2010
2Combined Antibody TherapeuticsIBA
06/2011 - 10/2010
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2011 - 12/2009
2AntibodiesIBA
04/2010 - 07/2007
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2010 - 06/2009
2Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
11/2007 - 02/2004
2Streptozocin (Streptozotocin)FDA Link
09/2007 - 01/2006
2Catalytic RNA (Ribozymes)IBA
06/2005 - 02/2004

Therapy/Procedure

20Therapeutics
10/2023 - 06/2002
3Nephrectomy
05/2016 - 06/2009
3Intravenous Administration
04/2015 - 10/2010
3Intraperitoneal Injections
06/2011 - 10/2010
2Drug Therapy (Chemotherapy)
02/2021 - 09/2017
2Intravenous Injections
01/2019 - 12/2009